Feldan Shuttle technology is at the heart of a collaborative research initiative supported by a CA$1.5 million grant from Médicament Québec, with backing from the Ministry of Economy, Innovation, and Energy (MEIE). The project, carried out in collaboration with Professor Bruno Gaillet (Laval University) and TransBIOTech, will integrate the Shuttle's endosomal escape function into lipid nanoparticles to accelerate the development of mRNA-based therapies.
